GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer
Authors
Keywords
GDF15, CA125, Epithelial ovarian carcinoma, Diagnosis, Chemotherapy
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1186/s12885-018-4246-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the efficacy and toxicity profile associated with intraperitoneal chemotherapy use in older women
- (2017) A. Crim et al. GYNECOLOGIC ONCOLOGY
- Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection
- (2017) Sarah E. Gill et al. GYNECOLOGIC ONCOLOGY
- Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer
- (2017) Nienke Zwakman et al. Journal of Gynecologic Oncology
- Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer
- (2017) Xiaobing Wang et al. Oncotarget
- Mucinous ovarian cancer: A therapeutic review
- (2016) Wen Xu et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Improved outcomes with dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
- (2016) David A. Becker et al. GYNECOLOGIC ONCOLOGY
- Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
- (2014) Xiaobing Wang et al. BMC CANCER
- Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer
- (2014) N.G. Alkema et al. GYNECOLOGIC ONCOLOGY
- FIGO staging for carcinoma of the vulva, cervix, and corpus uteri
- (2014) INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy
- (2013) Xiao-Bing Wang et al. CANCER SCIENCE
- Serum Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15): A Potential Screening Tool for the Prevention of Colon Cancer?
- (2012) D. A. Brown et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer
- (2011) A. C. Staff et al. CLINICAL CANCER RESEARCH
- Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality
- (2010) Fredrik E. Wiklund et al. AGING CELL
- Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer
- (2010) Anne Cathrine Staff et al. GYNECOLOGIC ONCOLOGY
- Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer
- (2010) Murielle Mimeault et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer
- (2009) D. A. Brown et al. CLINICAL CANCER RESEARCH
- Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer
- (2009) Woo Dae Kang et al. GYNECOLOGIC ONCOLOGY
- Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome
- (2009) Sophie Shnaper et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK–RhoA signaling pathway
- (2009) S Senapati et al. ONCOGENE
- Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
- (2009) Digant Gupta et al. Journal of Ovarian Research
- The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
- (2008) P de Graeff et al. BRITISH JOURNAL OF CANCER
- Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells
- (2008) Kwang-Kyu Kim et al. CARCINOGENESIS
- Macrophage Inhibitory Cytokine-1 Is Overexpressed in Malignant Melanoma and Is Associated with Tumorigenicity
- (2008) Glen M. Boyle et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer
- (2007) A.H.M.M. ARITS et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More